KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Cash (2016 - 2025)

Historic Change in Cash for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to -$15.0 million.

  • Arbutus Biopharma's Change in Cash rose 5150.93% to -$15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 16593.08%. This contributed to the annual value of $10.0 million for FY2024, which is 32366.96% up from last year.
  • Latest data reveals that Arbutus Biopharma reported Change in Cash of -$15.0 million as of Q3 2025, which was up 5150.93% from $336000.0 recorded in Q2 2025.
  • Over the past 5 years, Arbutus Biopharma's Change in Cash peaked at $46.9 million during Q3 2021, and registered a low of -$48.5 million during Q2 2021.
  • Moreover, its 5-year median value for Change in Cash was $746000.0 (2025), whereas its average is -$1.6 million.
  • Data for Arbutus Biopharma's Change in Cash shows a peak YoY increase of 60473.71% (in 2021) and a maximum YoY decrease of 34876.56% (in 2021) over the last 5 years.
  • Over the past 5 years, Arbutus Biopharma's Change in Cash (Quarter) stood at $31.4 million in 2021, then crashed by 78.43% to $6.8 million in 2022, then grew by 29.27% to $8.8 million in 2023, then tumbled by 48.78% to $4.5 million in 2024, then tumbled by 434.61% to -$15.0 million in 2025.
  • Its last three reported values are -$15.0 million in Q3 2025, $336000.0 for Q2 2025, and $746000.0 during Q1 2025.